Daan Gene released its 2026 interim report, showing total operating revenue of 328 million yuan and a net loss attributable to the parent of 120 million yuan, an improvement of 61.77 million yuan compared with the same period last year, marking a second consecutive year of narrowing losses. Net cash inflow from operating activities was 25.68 million yuan, up 36.33 million yuan year on year. The asset-liability ratio was 12.57%, gross margin was 33.81%, return on equity was negative 1.72%, and diluted earnings per share was negative 0.09 yuan. The number of shareholders was 135,100, and the top ten shareholders held 36.50% of total share capital.
Da An Gene Co Ltd of Sun Yat-Sen UniversityNet loss narrowed but still negative; report shows financial results without clear positive or negative driver.
